Charlotte Lozier Institute, Author at Lozier Institute

86 results

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

Richard Doerflinger, M.A.

October 5, 2020

ClosePlease login

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

Hannah Howard

October 1, 2020

ClosePlease login

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine. This analysis utilizes data from the primary scientific literature when available, along with data from clinical trial documents, reputable vaccine tracking websites, and published commercial information.1 It is the hope that by providing accurate data, recipients can make well-informed decisions regarding vaccine choices.

David Prentice, Ph.D.

September 30, 2020

ClosePlease login

New Abortion Trends in the United States: A First Look

Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List (SBA List), published a new report on emerging abortion trends in the United States. Ahead of the Centers for Disease Control and Prevention, as well as the Guttmacher Institute, CLI has the first analysis of trends revealed by the latest available state abortion reports from calendar year 2018

Tessa Longbons

September 22, 2020

ClosePlease login

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research. First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.

Tara Sander Lee, Ph.D.

James L. Sherley, M.D., Ph.D.

September 11, 2020

ClosePlease login

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court. In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Mary E. Harned, J.D.

August 19, 2020

ClosePlease login

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision. When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation was to improve abortion’s safety, as it was frequently claimed that many women were injured and sometimes died from illegal abortions. Recently, abortion advocates have changed their strategy. Whereas once they claimed they wanted abortion to be “safe, legal and rare,” now they favor immediate access and convenience to abortion for all women experiencing unintended pregnancies, regardless of whether it might be more dangerous for a woman, or whether the law prohibits it. Thus, they have begun encouraging women to seek more dangerous, “self-managed” abortions.

Ingrid Skop, M.D., FACOG

July 30, 2020

ClosePlease login

Addendum to Hyde @ 40: Analyzing the Impact of the Hyde Amendment

Addendum: Since the Charlotte Lozier Institute’s analysis of the Hyde Amendment was published in November of 2016, three states have changed how their Medicaid programs cover elective abortions.

Michael J. New, Ph.D.

July 21, 2020

ClosePlease login